Bill Huffnagle Email

CEO . CDx Diagnostics

Current Roles

Employees:
150
Revenue:
$28.1M
About
CDx Diagnostics® is the world's leader in the detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. Our tests are primarily used to help prevent cancer before it can start by identifying still-harmless dysplasias (precancers),and are also used to identify early stage cancers when they can be most easily cured. Clinicians use CDx® patented brush biopsy instruments to non-invasively collect a broad, full thickness tissue specimen of a suspect lesion. This unique tissue specimen is then subjected to specialized, computer-assisted laboratory analysis. These life saving tests are nationally available to gastroenterologists, otolaryngologists, oral surgeons, periodontists, and dentists. CDx Diagnostics® includes tests developed and provided by CDx Laboratories, Inc. Oral Cancer Prevention International, Inc. and its US and international laboratory affiliates.
CDx Diagnostics Address
2 Executive Boulevard
Suffern, NY
United States
CDx Diagnostics Email

Past Companies

CDx Diagnostics®CEO
StrykerPresident
Howmedica IncDirect Salesperson, Southern New Jersey market

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.